PegFilgrastim
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1132 publications
Impact of Primary Prophylactic Colony-Stimulating Factor Delivery Method on Febrile Neutropenia: Secondary Analysis of a Pragmatic Cluster Randomized Clinical Trial.
Journal: JCO oncology practice
Published: October 06, 2026
Atypical Bullous Sweet Syndrome.
Journal: Rhode Island medical journal (2013)
Published: September 25, 2026
Anaphylaxis to both pegfilgrastim and sargramostim in a patient with diffuse large B-cell lymphoma.
Journal: BMJ case reports
Published: September 24, 2026
Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin for Muscle-Invasive Bladder Cancer: Real-World Feasibility and Safety in a Resource-Constrained Setting.
Journal: JCO global oncology
Published: August 20, 2026
Prophylactic use of G-CSFs to reduce neutropenia rates in patients treated with antibody-drug conjugates: A literature review.
Journal: European journal of cancer (Oxford, England : 1990)
Published: June 29, 2026
Neoadjuvant Durvalumab ± Tremelimumab in Combination With Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Carcinoma: Results of the Phase I/II NEMIO Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 26, 2026
Biosimilar adoption and provider performance in Medicare value-based payment models.
Journal: The American journal of managed care
Published: May 26, 2026
Pharmacokinetics, pharmacodynamics, and radiomitigative efficacy of IEPA in a non-human primate model of acute radiation syndrome.
Journal: International journal of radiation biology
Published: May 26, 2026
Safety and efficacy of efbemalenograstim alfa for chemotherapy-induced neutropenia: A systematic review and meta-analysis of randomized controlled trials.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: May 19, 2026
Efficacy of prophylactic pegfilgrastim compared with therapeutic filgrastim for preventing febrile neutropenia during chemotherapy for musculoskeletal tumors: A single-center retrospective study.
Journal: Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association
Published: May 02, 2026
Risk of febrile neutropenia in breast cancer chemotherapy despite the prophylactic use of pegfilgrastim: a retrospective analysis.
Journal: Breast cancer (Tokyo, Japan)
Published: April 13, 2026
Growth factor supportive care for chemotherapy-induced neutropenia suppresses antitumour immunity in checkpoint blockade-responsive pancreatic cancer.
Journal: Immunotherapy advances
Published: April 09, 2026
Last Updated: 11/08/2026